PhAST

Boston, MA · Founded 2016 · Privately Held (backing)

Developer of an imaging technology designed to transform the fight against infectious diseases. PhAST is based in Boston, MA and was founded in 2016. Its last reported valuation was $242 million in Apr 2025. It has raised $18.6 million.

Last reported valuation
$241.7M
Oct 2026
Priced at
—
Total raised
$18.6M
Last round
—

Who backs PhAST?

10 investors
InvestorType
Endless Frontier Labs—
Labcorp Venture FundVenture capital
DAYLI PartnersVenture capital
BlueLion IncubatorOther
Laboratory Corporation of America—
Longitude Prize—
Massachusetts Life Sciences Center—
NAVER Cloud—
National Institute for Allergy and Infectious Disease—
SV Investment—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

PhAST investors

10 investors are on record for PhAST, including Endless Frontier Labs, Labcorp Venture Fund, DAYLI Partners and BlueLion Incubator.

Free account
More of PhAST with a free account
  • ·Watch PhAST: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like PhAST. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View